NPs Basic Information

Name
Citreohybridonol
Molecular Formula C28H36O8
IUPAC Name*
methyl (1R,2S,5R,9R,10S,12S,15S)-15-acetyloxy-6-hydroxy-4,5,7,10,14,14-hexamethyl-8,18-dioxo-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadeca-3,6-diene-9-carboxylate
SMILES
CC1=C[C@H]2[C@](C[C@H]3C4[C@]2(CC[C@@H](C4(C)C)OC(=O)C)C(=O)O3)([C@]5([C@@]1(C(=C(C5=O)C)O)C)C(=O)OC)C
InChI
InChI=1S/C28H36O8/c1-13-11-17-25(6,28(23(33)34-8)21(31)14(2)20(30)26(13,28)7)12-16-19-24(4,5)18(35-15(3)29)9-10-27(17,19)22(32)36-16/h11,16-19,30H,9-10,12H2,1-8H3/t16-,17-,18-,19?,25-,26-,27+,28+/m0/s1
InChIKey
MYLOBISKHDRNEW-USNZOBNTSA-N
Synonyms
Citreohybridonol
CAS NA
PubChem CID 101252260
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Steroids and steroid deri
        • Subclass: Steroid esters
          • Direct Parent: Steroid esters

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 500.6 ALogp: 3.3
HBD: 1 HBA: 8
Rotatable Bonds: 4 Lipinski's rule of five: Rejected
Polar Surface Area: 116.0 Aromatic Rings: 5
Heavy Atoms: 36 QED Weighted: 0.255

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.223 MDCK Permeability: 0.00003950
Pgp-inhibitor: 0.998 Pgp-substrate: 0.024
Human Intestinal Absorption (HIA): 0.017 20% Bioavailability (F20%): 0.228
30% Bioavailability (F30%): 0.838

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.558 Plasma Protein Binding (PPB): 68.08%
Volume Distribution (VD): 0.55 Fu: 30.31%

ADMET: Metabolism

CYP1A2-inhibitor: 0.003 CYP1A2-substrate: 0.428
CYP2C19-inhibitor: 0.036 CYP2C19-substrate: 0.88
CYP2C9-inhibitor: 0.042 CYP2C9-substrate: 0.055
CYP2D6-inhibitor: 0.001 CYP2D6-substrate: 0.097
CYP3A4-inhibitor: 0.596 CYP3A4-substrate: 0.899

ADMET: Excretion

Clearance (CL): 5.221 Half-life (T1/2): 0.141

ADMET: Toxicity

hERG Blockers: 0.002 Human Hepatotoxicity (H-HT): 0.2
Drug-inuced Liver Injury (DILI): 0.767 AMES Toxicity: 0.033
Rat Oral Acute Toxicity: 0.807 Maximum Recommended Daily Dose: 0.084
Skin Sensitization: 0.032 Carcinogencity: 0.623
Eye Corrosion: 0.992 Eye Irritation: 0.227
Respiratory Toxicity: 0.957
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001949 0.673 D0H2MO 0.301
ENC004115 0.658 D09WYX 0.262
ENC002012 0.655 D08BDT 0.262
ENC002033 0.558 D03ZZK 0.260
ENC003457 0.533 D0V2JK 0.252
ENC005963 0.524 D0X4RS 0.252
ENC005965 0.524 D01ZOG 0.247
ENC005964 0.521 D0G7KJ 0.245
ENC005629 0.333 D0X7XG 0.244
ENC003776 0.331 D0Q4SD 0.243
*Note: the compound similarity was calculated by RDKIT.